About RAL Diagnostics
RAL Diagnostics is a company based in Bordeaux (France) founded in 1916 was acquired by Cellavision in September 2019. RAL Diagnostics operates in a competitive market with competitors including Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.
- Headquarter Bordeaux, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Cellavision
(Sep 16, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of RAL Diagnostics
Detailed funding history for RAL Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in RAL Diagnostics
RAL Diagnostics has secured backing from 1 investor. Prominent investors backing the company include Cellavision.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Solutions for digital microscopy.
|
Locked | Locked | Locked |
Investor details for RAL Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RAL Diagnostics
Investment portfolio details for RAL Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RAL Diagnostics
Detailed financials for RAL Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ral Diagnostics Comparisons
Peer comparison for RAL Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RAL Diagnostics
RAL Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
|
| Locked | Locked | Locked |
Diversified instruments are developed for scientific and laboratory management.
|
Detailed competitors of RAL Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ral Diagnostics
Complete news archive for RAL Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RAL Diagnostics
RAL Diagnostics was founded in 1916.
RAL Diagnostics is headquartered in Bordeaux, France.
Frederic Imbs is the current CEO of RAL Diagnostics.
RAL Diagnostics manufactures and markets staining solution, reagents, and instruments for intelligent microscopy. The company offers dyes to identify cell and tissue morphology, parasites and bacteria reagents for hematology, bacteriology, parasitology, mycology, cytology, and histology, Fluo-Track (fluorescein) used as a tracer (sanitation, location of liquid paths) and the VB RAL kit (methylene blue) to determine purity ranges, relevant dyes for animal health, Semi-automated staining system,LED illuminator, and Automated staining system.
RAL Diagnostics's top competitors include Cepheid, Blackrock Neurotech and Agilent.
RAL Diagnostics has 1 investor. Key investors include Cellavision.